In the case–control study of Caucasians from Northern Italy, SOD2 Val105Val genotype, associated with defective function of SOD2 enzyme, increased BC risk (OR 1.91, 95 % CI 1.20–3.04). This evidence concerns the gene SOD2 and breast cancer.